Aaron Miller

Title: Innovations of Aaron Miller in Neoantigen Identification

Introduction

Aaron Miller is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of immunology, particularly in the identification of neoantigens. His work focuses on developing systems and methods that enhance the capabilities of engineered immune cells to target specific cancer-related peptides.

Latest Patents

Miller holds a patent for "Methods of neoantigen identification." This patent describes systems and methods for identifying neoantigen peptide candidates. These innovative systems can be utilized to generate engineered immune cells that specifically target neoantigen peptides. Notably, the methods do not require in silico epitope binding prediction algorithms, which simplifies the process. Additionally, the systems can identify neoantigens for cancers or tumors that exhibit a low mutational burden.

Career Highlights

Throughout his career, Aaron Miller has focused on advancing the understanding of immune responses to cancer. His innovative approaches have the potential to revolutionize cancer treatment by improving the precision of immune cell targeting. With a patent portfolio that includes 1 patent, Miller continues to push the boundaries of what is possible in cancer immunotherapy.

Collaborations

Miller has collaborated with notable researchers in the field, including Stephen P Schoenberger and Bjoern Peters. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.

Conclusion

Aaron Miller's work in neoantigen identification represents a significant advancement in cancer immunotherapy. His innovative methods and collaborative efforts are paving the way for more effective treatments in the fight against cancer.